257 related articles for article (PubMed ID: 25413413)
1. Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
Cui Y; Chen W; Kong FM; Olsen LA; Beatty RE; Maxim PG; Ritter T; Sohn JW; Higgins J; Galvin JM; Xiao Y
Pract Radiat Oncol; 2015; 5(2):e67-75. PubMed ID: 25413413
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
[TBL] [Abstract][Full Text] [Related]
3. The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
Lo AC; Liu M; Chan E; Lund C; Truong PT; Loewen S; Cao J; Schellenberg D; Carolan H; Berrang T; Wu J; Berthelet E; Olson R
J Thorac Oncol; 2014 Apr; 9(4):527-33. PubMed ID: 24736076
[TBL] [Abstract][Full Text] [Related]
4. Correlation of contouring variation with modeled outcome for conformal non-small cell lung cancer radiotherapy.
Jameson MG; Kumar S; Vinod SK; Metcalfe PE; Holloway LC
Radiother Oncol; 2014 Sep; 112(3):332-6. PubMed ID: 24853367
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of atlas and deep learning based automatic contouring for lung cancer.
Lustberg T; van Soest J; Gooding M; Peressutti D; Aljabar P; van der Stoep J; van Elmpt W; Dekker A
Radiother Oncol; 2018 Feb; 126(2):312-317. PubMed ID: 29208513
[TBL] [Abstract][Full Text] [Related]
6. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
7. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated radiotherapy of non-small-cell lung cancer incorporating SPECT ventilation imaging.
Munawar I; Yaremko BP; Craig J; Oliver M; Gaede S; Rodrigues G; Yu E; Reid RH; Leung E; Urbain JL; Chen J; Wong E
Med Phys; 2010 Apr; 37(4):1863-72. PubMed ID: 20443508
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
10. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
[TBL] [Abstract][Full Text] [Related]
11. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
[TBL] [Abstract][Full Text] [Related]
12. The impact of organ-at-risk contour variations on automatically generated treatment plans for NSCLC.
Vaassen F; Hazelaar C; Canters R; Peeters S; Petit S; van Elmpt W
Radiother Oncol; 2021 Oct; 163():136-142. PubMed ID: 34461185
[TBL] [Abstract][Full Text] [Related]
13. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
[TBL] [Abstract][Full Text] [Related]
14. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
15. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
[TBL] [Abstract][Full Text] [Related]
16. Combined PET/CT for IMRT treatment planning of NSCLC: contrast-enhanced CT images for Monte Carlo dose calculation.
Mönnich D; Lächelt S; Beyer T; Werner MK; Thorwarth D
Phys Med; 2013 Nov; 29(6):644-9. PubMed ID: 22975430
[TBL] [Abstract][Full Text] [Related]
17. Variations in the contouring of organs at risk: test case from a patient with oropharyngeal cancer.
Nelms BE; Tomé WA; Robinson G; Wheeler J
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):368-78. PubMed ID: 21123004
[TBL] [Abstract][Full Text] [Related]
18. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
Greco C; Rosenzweig K; Cascini GL; Tamburrini O
Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
[TBL] [Abstract][Full Text] [Related]
19. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
20. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
